Rosiglitazone/metformin
Alternative Names: Avandamet; Avandamet XR; Rosicon-MFLatest Information Update: 05 Nov 2023
At a glance
- Originator GlaxoSmithKline
- Developer GlaxoSmithKline; Glenmark Pharmaceuticals Ltd; GSK
- Class Antihyperglycaemics; Biguanides; Insulin sensitisers; Thiazolidinediones
- Mechanism of Action AMP activated protein kinase stimulants; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 2 diabetes mellitus